Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	75.95	57.45	26.68	44.96	10.35	11.69
Short-Term Investments	-	54.48	-	-	-	6.51
Trading Asset Securities	179.36	137.85	192.82	147.07	375.57	199.33
Cash & Short-Term Investments	255.31	249.78	219.5	192.02	385.92	217.53
Cash Growth	41.75%	13.80%	14.31%	-50.24%	77.41%	9.65%
Accounts Receivable	16.37	24.16	18.08	10.42	5.32	7.75
Other Receivables	1.57	1.19	1.29	1.33	1.59	1.43
Receivables	17.94	25.36	19.37	11.75	6.91	9.18
Inventory	41.4	34.28	26.2	29.41	21.18	16.53
Prepaid Expenses	-	-	0	0.37	0.02	-
Other Current Assets	7.53	2.99	4.64	4.7	3.12	9.32
Total Current Assets	322.18	312.41	269.71	238.25	417.14	252.56
Property, Plant & Equipment	302.73	309.45	319.15	319.82	231.46	117.98
Long-Term Investments	60.39	60.27	83.01	30.1	-	-
Other Intangible Assets	69.7	63.05	70.01	51.31	54.66	31.62
Long-Term Deferred Tax Assets	13.85	7.67	4.38	0.93	4.24	6.69
Long-Term Deferred Charges	24.31	34.12	26.61	34.56	27.16	38.43
Other Long-Term Assets	51.41	12.26	14.09	69.94	12.12	0.66
Total Assets	844.58	799.23	786.97	744.92	746.78	447.94
Accounts Payable	7.16	7.59	31.93	32.73	32.73	36.65
Accrued Expenses	7.35	22.16	18.85	16.91	14.65	13.43
Current Portion of Long-Term Debt	-	-	3.91	26.83	-	-
Current Portion of Leases	0.15	1.01	1.78	1.67	2.4	-
Current Income Taxes Payable	13.51	8.05	7.98	0.25	1.34	1.06
Current Unearned Revenue	3.34	6.02	1.2	1.45	0.86	3.89
Other Current Liabilities	14.01	2.64	2.47	1.92	2.2	1.2
Total Current Liabilities	45.51	47.48	68.12	81.77	54.18	56.23
Long-Term Debt	-	-	46.43	50.3	101.67	47.5
Long-Term Leases	-	-	1.01	2.85	6.62	-
Long-Term Unearned Revenue	47.43	51.8	35.28	6.8	8.44	4.56
Long-Term Deferred Tax Liabilities	0.26	0.29	0.26	0.62	-	-
Total Liabilities	93.21	99.57	151.11	142.34	170.92	108.3
Common Stock	66.61	66.52	66.06	66.06	66.06	49.55
Additional Paid-In Capital	479.31	463.95	441.66	436.19	436.19	259.83
Retained Earnings	215.68	179.53	126.96	99.29	70.01	26.62
Treasury Stock	-11.51	-11.51	-	-	-	-
Comprehensive Income & Other	1.28	1.18	1.18	1.04	-	-
Total Common Equity	751.37	699.66	635.86	602.58	572.26	336
Minority Interest	-	-	-	-	3.61	3.64
Shareholders' Equity	751.37	699.66	635.86	602.58	575.87	339.64
Total Liabilities & Equity	844.58	799.23	786.97	744.92	746.78	447.94
Total Debt	0.15	1.01	53.13	81.65	110.7	47.5
Net Cash (Debt)	255.16	248.77	166.36	110.37	275.22	170.03
Net Cash Growth	42.83%	49.53%	50.73%	-59.90%	61.87%	-14.30%
Net Cash Per Share	3.86	3.79	2.52	1.66	4.86	3.45
Filing Date Shares Outstanding	66.61	66.17	66.06	66.06	66.06	49.55
Total Common Shares Outstanding	66.61	66.17	66.06	66.06	66.06	49.55
Working Capital	276.67	264.93	201.59	156.48	362.96	196.33
Book Value Per Share	11.28	10.57	9.63	9.12	8.66	6.78
Tangible Book Value	681.67	636.61	565.85	551.27	517.6	304.38
Tangible Book Value Per Share	10.23	9.62	8.57	8.34	7.83	6.14
Buildings	-	293.55	289.32	277.02	-	-
Machinery	-	77.5	73.35	68.14	43.18	37.77
Construction In Progress	-	-	0.05	0.02	201.95	97.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.